GB1313659A - 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds - Google Patents

9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds

Info

Publication number
GB1313659A
GB1313659A GB3761269A GB1313659DA GB1313659A GB 1313659 A GB1313659 A GB 1313659A GB 3761269 A GB3761269 A GB 3761269A GB 1313659D A GB1313659D A GB 1313659DA GB 1313659 A GB1313659 A GB 1313659A
Authority
GB
United Kingdom
Prior art keywords
halogen
aralkylidenedioxy
alkylidenedioxy
alkylthio
july
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3761269A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of GB1313659A publication Critical patent/GB1313659A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB3761269A 1969-07-25 1969-07-25 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds Expired GB1313659A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3761269 1969-07-25

Publications (1)

Publication Number Publication Date
GB1313659A true GB1313659A (en) 1973-04-18

Family

ID=10397738

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3761269A Expired GB1313659A (en) 1969-07-25 1969-07-25 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds

Country Status (9)

Country Link
JP (1) JPS4831107B1 (enrdf_load_stackoverflow)
BR (1) BR6915284D0 (enrdf_load_stackoverflow)
CA (1) CA935429A (enrdf_load_stackoverflow)
DE (1) DE2036908C3 (enrdf_load_stackoverflow)
DK (1) DK128317B (enrdf_load_stackoverflow)
FR (1) FR2059570B1 (enrdf_load_stackoverflow)
GB (1) GB1313659A (enrdf_load_stackoverflow)
NL (1) NL7010980A (enrdf_load_stackoverflow)
ZA (1) ZA705120B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202521A (en) * 1966-07-29 1970-08-19 Glaxo Lab Ltd 01beta-CHLORO-19-NOR-STEROIDS

Also Published As

Publication number Publication date
ZA705120B (en) 1971-05-27
DK128317B (da) 1974-04-08
NL7010980A (enrdf_load_stackoverflow) 1971-01-27
DE2036908A1 (de) 1971-02-04
BR6915284D0 (pt) 1973-02-08
CA935429A (en) 1973-10-16
FR2059570A1 (enrdf_load_stackoverflow) 1971-06-04
JPS4831107B1 (enrdf_load_stackoverflow) 1973-09-26
DE2036908C3 (de) 1980-02-07
DE2036908B2 (enrdf_load_stackoverflow) 1979-06-13
FR2059570B1 (enrdf_load_stackoverflow) 1974-09-20

Similar Documents

Publication Publication Date Title
Tietze Fertility after discontinuation of intrauterine and oral contraception
GB1446626A (en) Composition for sustained release of a medicament and method of using same
ATE158717T1 (de) Verfahren und formulierungen zur kontrazeption und zur behandlung von benignen gynäkologischen störungen
GB1313659A (en) 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
IE34308B1 (en) 11beta,13beta dialkylgona-1,3,5(10)-trien-3-ol 3-cycloalkyl ethers
Goldzieher Symposium on steroid hormones. 1. Synthetic progestational steroids. Their significance and use
Savage The use of Depo-Provera in East London
FR2097045A1 (en) 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders
ES363068A1 (es) Un procedimiento para la preparacion de 11-beta-cloro-este-roides.
GB1094806A (en) Unsaturated steroid compounds and processes for their preparation
GB1260463A (en) 11beta-BROMO-19-NOR-STEROIDS
IL32901A (en) Glycosidyl and glycuronosidyl steroids of the estrane series,preparation thereof and use as estrogenic agents
CH474499A (fr) Procédés de préparation d'éthers-oxydes de stéroïdes insaturés
AU270774B2 (en) 17a-(AND 17a-(2-ALKNYL) ESTRA-1,3,5(10)-TRIENE-3,17B-DIOLS, ESTERS THEREOF, AND PROCESS OF PREPARATION
Talwar et al. Progestagen-only oral contraceptive for breast-feeding women
CH453349A (fr) Procédé de préparation d'hormones progestationnelles
GB1116795A (en) An oral contraceptive preparation
FR88809E (fr) Composés stéroïdes dérivant de l'oestrone et de l'oestradiol et leurs procédésde préparation
GB1145393A (en) Improvements in or relating to 17-‡-(alka-1',3'-diynyl)-steroids
GB953741A (en) Pharmaceutical anti-inflammatory compositions containing a substituted anthranilic acid
GB1311680A (en) Contraceptive preparations and method of contraception
FR1394701A (fr) Composés stéroïdes dérivant de l'oestrone et de l'oestradiol et leurs procédésde préparation
Shah Use of progestational compounds in gynaecology and obstetrics
CA739462A (en) 3-keto unsaturated steroid compounds, compositions containing same and process for the preparation thereof
ES395365A1 (es) Procedimiento para la obtencion de agentes anticonceptivos.

Legal Events

Date Code Title Description
PS Patent sealed
426 Order made revoking patent and granting patent of addition in lieu thereof (sect. 26(2)/1949)
PCNP Patent ceased through non-payment of renewal fee